Resources

The latest in immuno research, from the discovery & development of cell & antibody therapies through to omics-based approaches and clinical case studies

Biomarkers in Immuno-Oncology

New Multi-Omic AI-Driven Initiative for Immuno-Oncology Biomarker Development

The team aims to establish a consortium of cancer centres to join the project of developing biomarkers from multi-omic analysis.
Biomarkers in Immuno-Oncology

Oncolytic Virus Immunotherapy: A Revolutionary Approach in Immuno-Oncology

Explore the cutting-edge of oncolytic virus immunotherapy in immuno-oncology: the viruses revolutionizing cancer treatment and the promise they hold for future therapies.
Biomarkers in Immuno-Oncology

NeoGenomics: Connect With Us to Explore How Our Oncology Data and Expertise Can Help Your Team

Data-driven insights from the largest volume cancer-testing lab in the U.S.
Biomarkers in Immuno-Oncology

Simplify Spatial Imaging Maxpar IMC Cell Segmentation Kit

High-plex imaging starts with robust cell segmentation
Biomarkers in Immuno-Oncology

Bioanalytical Solutions for CAR-T and NK Cell Therapies

Synexa Life Sciences is a bioanalytical and biomarker services laboratory specializing in the development and validation of complex and custom designed assays with progression into clinical trial sample analysis.
Biomarkers in Immuno-Oncology

Synexa Life Sciences: Bioanalytical Solutions for Immuno-oncology Therapeutics

Global leaders in specialist biomarker and bioanalysis research services.
Biomarkers in Immuno-Oncology

Synexa Biomarker and Bioanalytical Solutions

Complex solutions delivered on time and within budget.
Biomarkers in Immuno-Oncology

Rules Based Medicine: Human Services Catalog

Rules-Based Medicine (RBM), a Q2 Solutions Company, is a CLIA-certified immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services and products.
Biomarkers in Immuno-Oncology

Rules Based Medicine: Operational Procedures

Rules-Based Medicine (RBM), a Q2 Solutions Company, has spent over 20 years developing and optimizing multiplex immunoassays based on the Luminex xMAP® technology.
Biomarkers in Immuno-Oncology

NeoGenomics: Transforming Care for Cancer Patients

Comprehensive service overview for pharmaceutical partners
Biomarkers in Immuno-Oncology

SyncroPatch 384 For All Your Patch Clamp Needs

Unprecedented flexibility for HTS automated patch clamp.
Biomarkers in Immuno-Oncology

Nanion: Cell Analytics Brochure

Next level live-cell kinetic and phenotypic assays.
Biomarkers in Immuno-Oncology

AtlaZ: Quantitative Live-Cell Analytics

Welcome to the next level of live-cell analytics.
Biomarkers in Immuno-Oncology

Hyperion XTi™ Imaging System

Uniquely designed for clinical research.
Biomarkers in Immuno-Oncology

Immune Cell-mediated Killing of A549 Cancer Target Cells in Real-time

Nanion Technologies GmbH, Munich. TUM, Munich
Biomarkers in Immuno-Oncology

Exploring Oncology Biomarkers in Early Clinical Trials and Precision Medicine: Challenges and Opportunities

The importance of validating hypotheses, understanding the biology of cancer progression, and utilising biomarkers in early screening to stratify populations and improve clinical endpoints.
Biomarkers in Immuno-Oncology

A ‘New Age’ of Biomarker Technology? Understanding Identification & Validation of IO Biomarkers

Developing and validating IO biomarkers present challenges, such as working with challenging sample types, interpreting sequencing data, and integrating new technologies into the clinic.
Biomarkers in Immuno-Oncology

Axion Biosystems: Organoid Analysis Module

Robust organoid quantification and monitoring.
Biomarkers in Immuno-Oncology

Volition: Nu.Q Discover

An innovative solution to profiling nucleosomes.
Biomarkers in Immuno-Oncology

ChemPartner: GPCR/Transporter/Ion Channel Screening

Overview of Capabilities.
Biomarkers in Immuno-Oncology

Improving Patient Response Through Effective Biomarker Development

Oxford Global's panel discussion brings together expert scientists in the field of immunology and biomarker development.
Biomarkers in Immuno-Oncology

Enabling Ultrasensitive Protein Quantification with the Quanterix Homebrew Kit

Unique Homebrew Kits give researchers the flexibility to develop custom Simoa assays.
Biomarkers in Immuno-Oncology

Cancer Invasion Protocol - CellLink

Biomarkers in Immuno-Oncology

NeXT Personal - Personalis

Biomarkers in Immuno-Oncology

NeXT Liquid Biopsy - Personalis

Biomarkers in Immuno-Oncology

Bioassays for Biologics - Promega

Biomarkers in Immuno-Oncology

HiBiT Protein Tagging System

Biomarkers in Immuno-Oncology

Three Leading Perspectives on Biomarker Diagnostic Discovery in Immuno-oncology

Early and effective treatment of cancers could mean the difference between life and death. Therefore, companion diagnostics and biomarker discovery could be considered one of the most important avenues to explore in immuno-oncology.
Biomarkers in Immuno-Oncology

Perfecting Precision Medicine: The Promise of Biomarkers and Spatial Biology

What is the future of precision medicine for immuno-oncology, and how can we achieve it? In this Insight Article, we sat down with senior representatives from the University of Michigan, the Beth Israel Deaconess Medical Center / Harvard Medical School, and The Institute of Cancer Research, London, to discover more about harnessing the potential of spatial biology and predictive biomarkers to achieve targeted results.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things immuno